The physicial barriers to provide separation between the vaxxed and unvaxxed at an outdoor Christmas market in Luxembourg is summarily dismantled

Federal Judge Collyer last week dismissed a lawsuit challenging Biothrax’s license on the basis that efficacy has not been demonstrated. The suit contended that anthrax vaccine had never been approved for its current intended use, inhalation anthrax. The judge ruled that FDA is, in essence, the arbiter of the science and can interpret the data…

This Wall Street Journal article provides a fascinating glimpse into what I will call, for lack of a better term, scientific xenophobia.  It suggests an unwillingness to grapple with important data originating from another nation, perhaps because the data suggest US public health professionals should consider veering from the federal flu vaccine strategy being followed….

Monsanto (NYSE:MON), the Missouri-based seed company, has stopped lobbying for GMO crops in Europe. The company is backing off because it has accepted that there is low demand for genetically modified plants in Europe. A Monsanto Germany spokeswoman, Ursula Lüttmer-Ouazane said ”We’ve come to the conclusion that this has no broad acceptance at the moment.” She also noted that it was “counterproductive…

The Globe updates us on the NECC tragedy/scandal. The outbreak of fungal meningitis due to contaminated drugs from New England Compounding Center  brings to mind a 1997 FDA inspection and report of the Lansing, Michigan anthrax vaccine manufacturer, which at that time was a state of Michigan subsidiary:  Michigan Biologic Products Institute.  Many of the…

For Immediate ReleaseMarch 6, 2009 Washington D.C.FBI National Press Office(202) 324-3691 FBI Responds to Science Issues in Anthrax Case FBI Laboratory Director D. Christian Hassell, PhD issued the following statement: During a recent American Society for Microbiology Biodefense (ASMBD) meeting in Baltimore , Maryland , questions were raised regarding two scientific analyses conducted during the…

Prof Stuart Newman believes genetic engineering may have been involved at some point in the virus’s history Another expert on biotechnology has attacked the evidence being used to quash suggestions that SARS-CoV-2, the virus strain that causes COVID-19, might have been genetically engineered. Professor Stuart Newman, professor of cell biology and anatomy at New York…